21
Oct
2015
To evaluate the efficacy of exploratory compounds in different pain areas, various classical preclinical models are routinely used. For early drug discovery purposes, however, the full characterization package can be long and significantly expensive. To address this issue, we have developed an innovative screening tool, the ALGOGramTM, a panel of behavioral pain models each validated with the most clinically relevant drugs.